Centre hospitalier departemental Vendee

La Roche-sur-Yon 85925 CEDEX 9

0 studies enrolling now · 3 studies all time

What they study most

Castration-Resistant Prostate Cancer, Locally Advanced or Metastatic Unresectable Urothelial Cancer, Non-Small Cell Lung Cancer

Studies at this site

• Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread — Completed
• Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Running, not enrolling
• Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy — Completed